Revanesse Versa+ by Prollenium Medical Technologies is an FDA-approved hyaluronic acid filler known for its smooth, homogeneous formulation and consistently low post-injection swelling in clinical studies. A versatile HA filler for facial volume, wrinkle correction, and lip augmentation.
Revanesse Versa+ uses a smooth, particle-free HA formulation with a consistent molecular structure throughout — producing a homogeneous gel that integrates naturally into tissue. In the pivotal FDA clinical study, Versa+ showed significantly less post-injection swelling compared to Juvederm Ultra Plus, making it a strong choice for patients with busy schedules or social commitments.
Clinical data from the Versa+ FDA approval study showed that patients treated with Revanesse Versa+ experienced notably less swelling at 2 weeks post-injection compared to patients treated with a leading competitive filler. For patients who are concerned about post-injection swelling — particularly for events or social occasions — this is a meaningful clinical advantage.
Like other HA fillers, Revanesse Versa+ is gradually metabolized by the body. Results for nasolabial folds and facial wrinkles were maintained through 12 months in clinical studies. Lip augmentation results typically require maintenance at 6–9 months. Individual results vary.
Use of Revanesse Versa+ for areas beyond FDA-approved indications is off-label — standard and legal in aesthetic medicine practice. Your injector will discuss appropriate areas for your goals at your consultation.
Book a filler consultation at medAge. We carry the full range of HA and CaHA fillers and will recommend the right product for your specific anatomy, goals, and post-injection schedule.
$75 new patient deposit · applied toward your first treatment
Financing available through PatientFi — pay as low as $97/mo. See payment options →